Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates

被引:225
作者
Coste, Alix
Selmecki, Anna
Forche, Anja
Diogo, Dorothee
Bougnoux, Marie-Elisabeth
d'Enfert, Christophe
Berman, Judith
Sanglard, Dominique
机构
[1] Univ Lausanne, Inst Microbiol, CH-1011 Lausanne, Switzerland
[2] Univ Hosp Ctr, CH-1011 Lausanne, Switzerland
[3] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA
[4] Inst Pasteur, Dept Genomes & Genet, INRA USC2019, Unite Biol & Pathogenecite Fong, Paris, France
关键词
D O I
10.1128/EC.00151-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
TAC1 (for transcriptional activator of CDR genes) is critical for the upregulation of the ABC transporters CDR1 and CDR2, which mediate azole resistance in Candida albicans. While a wild-type TAC1 allele drives high expression of CDR1/2 in response to inducers, we showed previously that TAC1 can be hyperactive by a gain-of-function (GOF) point mutation responsible for constitutive high expression of CDR1/2. High azole resistance levels are achieved when C. albicans carries hyperactive alleles only as a consequence of loss of heterozygosity (LOH) at the TAC1 locus on chromosome 5 (Chr 5), which is linked to the mating-type-like (MTL) locus. Both are located on the Chr 5 left arm along with ERG11 (target of azoles). In this work, five groups of related isolates containing azole-susceptible and -resistant strains were analyzed for the TAC1 and ERG11 alleles and for Chr 5 alterations. While recovered ERG11 alleles contained known mutations, 17 new TAC1 alleles were isolated, including 7 hyperactive alleles with five separate new GOF mutations. Single-nucleotide-polymorphism analysis of Chr 5 revealed that azole-resistant strains acquired TAC1 hyperactive alleles and, in most cases, ERG11 mutant alleles by LOH events not systematically including the MTL locus. TAC1 LOH resulted from mitotic recombination of the left arm of Chr 5, gene conversion within the TAC1 locus, or the loss and reduplication of the entire Chr 5. In one case, two independent TAC1 hyperactive alleles were acquired. Comparative genome hybridization and karyotype analysis revealed the presence of isochromosome 5L [i(5L)] in two azole-resistant strains. i(5L) leads to increased copy numbers of azole resistance genes present on the left arm of Chr 5, among them TAC1 and ERG11. Our work shows that azole resistance was due not only to the presence of specific mutations in azole resistance genes (at least ERG] I and TAC1) but also to their increase in copy number by LOH and to the addition of extra Chr 5 copies. With the combination of these different modifications, sophisticated genotypes were obtained. The development of azole resistance in C. albicans is therefore a powerful instrument for generating genetic diversity.
引用
收藏
页码:1889 / 1904
页数:16
相关论文
共 57 条
  • [1] An update on antifungal targets and mechanisms of resistance in Candida albicans
    Akins, RA
    [J]. MEDICAL MYCOLOGY, 2005, 43 (04) : 285 - 318
  • [2] Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance
    Albertson, GD
    Niimi, M
    Cannon, RD
    Jenkinson, HF
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) : 2835 - 2841
  • [3] Rad52 depletion in Candida albicans triggers both the DNA-damage checkpoint and filamentation accompanied by but independent of expression of hypha-specific genes
    Andaluz, E
    Ciudad, T
    Gómez-Raja, J
    Calderone, R
    Larriba, G
    [J]. MOLECULAR MICROBIOLOGY, 2006, 59 (05) : 1452 - 1472
  • [4] Loss and fragmentation of chromosome 5 are major events linked to the adaptation of rad52-ΔΔ strains of Candida albicans to sorbose
    Andaluz, Encarnacion
    Gomez-Raja, Jonathan
    Hermosa, Belen
    Ciudad, Toni
    Rustchenko, E.
    Calderone, Richard
    Larriba, German
    [J]. FUNGAL GENETICS AND BIOLOGY, 2007, 44 (08) : 789 - 798
  • [5] Barker Katherine S, 2006, Curr Infect Dis Rep, V8, P449
  • [6] Molecular and phenotypic characterization of yeast PDR1 mutants that show hyperactive transcription of various ABC multidrug transporter genes
    Carvajal, E
    vandenHazel, HB
    CybularzKolaczkowska, A
    Balzi, E
    Goffeau, A
    [J]. MOLECULAR AND GENERAL GENETICS, 1997, 256 (04): : 406 - 415
  • [7] Virulence and karyotype analyses of rad52 mutants of Candida albicans:: Regeneration of a truncated chromosome of a reintegrant strain (rad52/RAD52) in the host
    Chauhan, N
    Ciudad, T
    Rodríguez-Alejandre, A
    Larriba, G
    Calderone, R
    Andaluz, E
    [J]. INFECTION AND IMMUNITY, 2005, 73 (12) : 8069 - 8078
  • [8] CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1
    Chen, CG
    Yang, YL
    Shih, HI
    Su, CL
    Lo, HJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) : 4505 - 4512
  • [9] Homologous recombination in Candida albicans:: role of CaRad52p in DNA repair, integration of linear DNA fragments and telomere length
    Ciudad, T
    Andaluz, E
    Steinberg-Neifach, O
    Lue, NF
    Gow, NAR
    Calderone, RA
    Larriba, G
    [J]. MOLECULAR MICROBIOLOGY, 2004, 53 (04) : 1177 - 1194
  • [10] A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans
    Coste, A
    Turner, V
    Ischer, F
    Morschhäuser, J
    Forche, A
    Selmecki, A
    Berman, J
    Bille, J
    Sanglard, D
    [J]. GENETICS, 2006, 172 (04) : 2139 - 2156